For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Testing services for ADME outside the human body
Scope of the Report:
Early stages of drug discovery research, including the identification of relevant biological targets and viable lead compounds with therapeutic potential, play a crucial role in the overall success of drug candidates in preclinical and clinical studies. In particular, ADME studies are considered essential for determining the safety and efficacy of drug candidates. Currently, many contract research organizations (CROs) claim to have the necessary capabilities to provide in vitro ADME services.
The global In Vitro ADME Testing Services market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In Vitro ADME Testing Services.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the In Vitro ADME Testing Services market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In Vitro ADME Testing Services market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Albany Molecular Research (AMRI)
- Charles River Laboratories
- Pharmaceutical Product Development (PPD)
- RTI International
- Eurofins Scientific
- Tecan Group
- GVK Biosciences
- Sai Life Sciences
- Shanghai Medicilon
- Syngene International
- WuXi AppTec
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Small Molecules
Market Segment by Applications, can be divided into
- Lood to Plasma Ratio
- Caco-2 Permeability
- Cytochrome (CYP) Enzyme Induction / Inhibition
- Metabolic Stability
- Plasma Protein Binding
- Reaction Phenotyping